全文获取类型
收费全文 | 116259篇 |
免费 | 7315篇 |
国内免费 | 5682篇 |
专业分类
耳鼻咽喉 | 868篇 |
儿科学 | 2447篇 |
妇产科学 | 3325篇 |
基础医学 | 8552篇 |
口腔科学 | 3116篇 |
临床医学 | 11874篇 |
内科学 | 14169篇 |
皮肤病学 | 1147篇 |
神经病学 | 2643篇 |
特种医学 | 5363篇 |
外国民族医学 | 1篇 |
外科学 | 9046篇 |
综合类 | 26201篇 |
现状与发展 | 17篇 |
一般理论 | 9篇 |
预防医学 | 13098篇 |
眼科学 | 2108篇 |
药学 | 10490篇 |
82篇 | |
中国医学 | 10275篇 |
肿瘤学 | 4425篇 |
出版年
2024年 | 278篇 |
2023年 | 906篇 |
2022年 | 1939篇 |
2021年 | 2288篇 |
2020年 | 2095篇 |
2019年 | 1161篇 |
2018年 | 1411篇 |
2017年 | 1698篇 |
2016年 | 1482篇 |
2015年 | 2274篇 |
2014年 | 3020篇 |
2013年 | 4134篇 |
2012年 | 5766篇 |
2011年 | 8680篇 |
2010年 | 6501篇 |
2009年 | 5458篇 |
2008年 | 5862篇 |
2007年 | 5571篇 |
2006年 | 5154篇 |
2005年 | 5543篇 |
2004年 | 9116篇 |
2003年 | 8042篇 |
2002年 | 6388篇 |
2001年 | 5240篇 |
2000年 | 3338篇 |
1999年 | 3641篇 |
1998年 | 2532篇 |
1997年 | 2279篇 |
1996年 | 1623篇 |
1995年 | 1389篇 |
1994年 | 1414篇 |
1993年 | 1918篇 |
1992年 | 1689篇 |
1991年 | 1479篇 |
1990年 | 1116篇 |
1989年 | 963篇 |
1988年 | 743篇 |
1987年 | 629篇 |
1986年 | 632篇 |
1985年 | 352篇 |
1984年 | 217篇 |
1983年 | 189篇 |
1982年 | 139篇 |
1981年 | 134篇 |
1980年 | 126篇 |
1979年 | 128篇 |
1977年 | 123篇 |
1976年 | 119篇 |
1975年 | 123篇 |
1974年 | 100篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
中药生产过程质量控制关键技术研究进展 总被引:10,自引:8,他引:2
中医药发展已上升到国家战略层面,在医药行业贯彻实施"中国制造2025"战略的新形势下,中药生产过程质量控制是中药工业需要加快突破的关键领域之一。对中药生产过程质量控制领域在工艺设计、分析检测、过程建模、制造装备等方面的关键共性问题进行解析,综述了中药生产过程质量控制体系中工艺过程理解、生产过程实时分析方法开发、过程控制策略建立3个方面的研究进展;并结合企业研究实践,介绍了质量源于设计(quality by design,Qb D)、过程分析技术(process analytical technology,PAT)、实验设计(design of experiment,DOE)、多变量统计分析等关键技术在上述3个研究方向中的应用进展,分析了实际工业应用的难点问题并对其应用前景进行展望,旨在为中药企业应用和提升生产过程质量控制技术提供参考。 相似文献
2.
3.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis 下载免费PDF全文
4.
María Cabrerizo Gloria Trallero María José Pena Amaia Cilla Gregoria Megias Carmen Mu?oz-Almagro Eva Del Amo Diana Roda Ana Isabel Mensalvas Antonio Moreno-Docón Juan García-Costa Nuria Rabella Manuel Ome?aca María Pilar Romero Sara Sanbonmatsu-Gámez Mercedes Pérez-Ruiz María José Santos-Mu?oz Cristina Calvo And the study group of “Enterovirus parechovirus infections in children under ?years-old Spain” PI- 《European journal of pediatrics》2015,174(11):1511-1516
5.
6.
7.
Bi-Hua BIE Yong CHEN Zhi-Qi ZHAO Institute of Neurobiology Fu-Dan University Shanghai China Institute of Shanghai Physiology Chinese Academy of Sciences Shanghai China 《中国神经科学杂志》2006,(2)
Objective Ligustrazine, also named as tetramethylpyrazine, is a compound purified from Ligusticum chuanxiong hort and has ever been testified to be a calcium antagonist. The present investigation was to determine the antinoci-ceptive effect of ligustrazine and, if any, the peripheral ionic mechanism involved. Methods Paw withdrawal Latency ( PWL) to noxious heating was measured in vivo and whole-cell patch recording was performed on small dorsal root ganglion (DRG) neurons. Results Intraplantar injection of ligustrazine (0.5 mg in 25μl) significantly prolonged the withdrawal latency of ipsilateral hindpaw to noxious heating in the rat. Ligustrazine not only reversibly inhibited high-voltage gated calcium current of dorsal root ganglion (DRG) neuron in dose-dependent manner with IC50 of 1.89 mmol/L, but also decreased tetrodotoxin (TTX) -resistant sodium current in relatively selective and dose-dependent manner with IC50 of 2.49 mmol/L. Conclusion The results suggested that ligustrazine could elevate the threshold of thermal nociception through inhibiting the high-voltage gated calcium current and TTX-resistant sodium current of DRG neuron in the rat. 相似文献
8.
9.
GIUSEPPE BORIANI MAURO BIFFI MAURIZIO RUSSO† MAURIZIO LUNATI‡ GIANLUCA BOTTO¶ ALESSANDRO PROCLEMER§ GIUSEPPE VERGARA WERNER RAHUE†† CRISTIAN MARTIGNANI RENATO RICCI† MASSIMO SANTINI† On Behalf of the SEARCH MI Registry Italian Investigators 《Pacing and clinical electrophysiology : PACE》2006,29(S2):S29-S34
Background: Large randomized trials show that in appropriately selected patients with left ventricular dysfunction, implantable cardioverter-defibrillators (ICDs) can improve overall survival at 2–5 years. Since direct implementation of the criteria used in the MADIT II and SCD-HeFT will lead to a marked rise in ICD implants, there is a growing fear that increased use of ICDs may cause a dramatic burden to health care systems. The ICD has traditionally been seen as an expensive form of treatment, which is difficult to accept at the first look. This is mainly due to the nonlinear character of the ICD investment, characterized by high initial expenditure, followed by a deferred pay-off in terms of clinical benefits. Cost-effectiveness analysis may help provide a different perspective on the problem of ICD cost, as may estimation of the daily cost of ICD treatment, assuming a time horizon of 5–7 years—a particularly interesting subject for further registry studies.
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
10.